01 July 1996
Expression of the binding sites for anti-zona pellucida antibodies in the oviduct
Zuzana Jirsova, Jindrich MartinekMed Sci Monit 1996; 2(4): BR391-396 :: ID: 499900
Abstract
Antibodies against zona pellucida (ZP) have recently aroused interest for their contraceptive activity in vitro and in vivo. In our study we attempted to use anti-ZP antibodies for detection of binding sites for ZP antigens on the oviductal epithelium considering the fact that in the course of fertilization and early stages of embryonic development the ZP is denuded and comes into intimate contact with the lining of the oviduct. The binding sites for anti-rat ZP antibodies (ARZPAb) prepared by immunization of a BALB/c mouse were detected using an indirect immunoperoxidase technique on the ZP of oviductal oocytes and on the luminal surface of the oviductal epithelium of the isthmus under the light microscope. For the electron microscopic detection of binding sites for anti-rat ZP antibodies post-embbedding immunogold technique was used. The binding sites were expressed in the ZP and on the apical membrane of the oviductal epithelium as well. The TEC-02 IgM monoclonal antibody recognizing the TEC-2 epitope carried on the ZP of a mouse egg was used for detection of the binding sites in the mouse. The binding of TEC-02 antibody was confirmed in the ZP of ovarian oocytes. In the fimbrial and ampullar parts of the oviduct the binding sites were detected on individual epithelial cells, in the isthmus the expression of TEC-2 epitope was more frequent. No binding sites for anti-ZP antibodies were found in the uterine and vaginal epithelium. The findings of binding of ARZPAb detected on the oviductal epithelium of the rat and mouse support the hypothesis of the presence of membrane receptors for ZP antigens in the oviduct.
Keywords: oviduct, Zona Pellucida, Binding Sites, Antibodies, antigen determinants
Editorial
01 January 2026 : Editorial
Editorial: Increasing Awareness of Lung Cancer in Non-Smokers and Never-Smokers Challenges Current Approaches to Prevention and ScreeningDOI: 10.12659/MSM.952454
Med Sci Monit 2026; 32:e952454
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






